Immunic Inc’s filing revealed that its Director Rudick Richard Alan acquired Company’s shares for reported $0.1 million on Nov 12 ’24. In the deal valued at $1.15 per share,87,300 shares were bought. As a result of this transaction, Rudick Richard Alan now holds 87,300 shares worth roughly $87300.0.
H.C. Wainwright initiated its Immunic Inc [IMUX] rating to a Buy in a research note published on November 25, 2024; the price target was $10. B. Riley Securities began covering IMUX with “Buy” recommendation on August 27, 2024. SVB Leerink revised its rating on October 21, 2022. It rated IMUX as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of IMUX
On Monday, Immunic Inc [NASDAQ:IMUX] saw its stock fall -1.96% to $1.00. Over the last five days, the stock has gained 4.93%. Nevertheless, the stocks have fallen -13.04% over the past one year. While a 52-week high of $2.11 was reached on 01/06/25, a 52-week low of $0.92 was recorded on 01/21/25. SMA at 50 days reached $1.1005, while 200 days put it at $1.2877.
Levels Of Support And Resistance For IMUX Stock
The 24-hour chart illustrates a support level at 0.9767, which if violated will result in even more drops to 0.9533. On the upside, there is a resistance level at 1.0367. A further resistance level may holdings at 1.0733. The Relative Strength Index (RSI) on the 14-day chart is 43.67, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0191, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.08%. Stochastics %K at 35.77% indicates the stock is a holding.
How much short interest is there in Immunic Inc?
A steep rise in short interest was recorded in Immunic Inc stocks on 2024-12-31, growing by 1.45 million shares to a total of 5.64 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 4.19 million shares. There was a rise of 25.7%, which implies that there is a positive sentiment for the stock.
